Reference case
PRESSURE ULCERS, EVENT
The economic evaluation was framed in terms of a cost-minimization analysis. With the model carried out, it was found that for adults over 18 years of age hospitalized, whether medical or surgical ICU patients, the use of HCD alternative or petrolatum for the prevention of pressure ulcers did show the same effectiveness (0.82) but presented an incremental cost of 52.11 USD, that is more expensive and just as effective, so the HCD it is not a cost-effective option. (Table Cost effectiveness results.Results of the 1-way deterministic sensitivity analysis probability of developing PU with dressing.Finally, considering that the probability of developing PUs plays an essential role in the results of the model, a two-way multivariate analysis was performed, considering the probabilities of the event occurring. In the following graph (Fig. Results of the 2-way deterministic sensitivity analysis according to the probability of developing Pus with dressing and with moisturizing cream. The blue area corresponds to the dressing, which indicates that it is less likely to be cost-effective.